Coherus Biosciences's market cap is currently $174.34M. The company's EPS TTM is $-0.39; its P/E ratio is 5.55; Coherus Biosciences is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
